Examining the Association Between the COVID-19 Pandemic and the Rate of Diagnostic Tests for Breast, Cervical, and Colorectal Cancer in Manitoba, Canada
Technology in Cancer Research & Treatment · 2024
DOI: 10.1177/15330338241263616 ↗Kurz gefasst
Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2024. Verfasst von Kathleen M Decker und 10 weiteren Autor:innen. Beteiligte Einrichtung: Paul Albrechtsen Research Institute CancerCare Manitoba, Winnipeg, MB, Canada. Hauptthemen laut MEDLINE: COVID-19, Breast Neoplasms, Colorectal Neoplasms, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CancerCare Manitoba Foundation, Research Manitoba, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Background
Strategies to minimize the impact of the COVID-19 pandemic led to a reduction in diagnostic testing. It is important to assess the magnitude and duration of this impact to plan ongoing care and avoid long-lasting impacts of the pandemic.
Objective
We examined the association between the COVID-19 pandemic and the rate of diagnostic tests for breast, cervical, and colorectal cancer in Manitoba, Canada. Design and Participants: A population-based, cross-sectional study design with an interrupted time series analysis was used that included diagnostic tests from January 1, 2015 until August 31, 2022.
Setting
Manitoba, Canada. Main Outcomes: Outcomes included mammogram, breast ultrasound, colposcopy, and colonoscopy rates per 100,000. Cumulative and percent cumulative differences between the fitted and counterfactual number of tests were estimated. Mean, median, and 90th percentile number of days from referral to colonoscopy date by referral type (elective, semiurgent, urgent) were determined.
Results
In April 2020, following the declaration of the COVID-19 public health emergency, bilateral mammograms decreased by 77%, unilateral mammograms by 70%, breast ultrasounds by 53%, colposcopies by 63%, and colonoscopies by 75%. In Winnipeg (the largest urban center in the province), elective and semiurgent colonoscopies decreased by 76% and 39%, respectively. There was no decrease in urgent colonoscopies. As of August 2022, there were an estimated 7270 (10.7%) fewer bilateral mammograms, 2722 (14.8%) fewer breast ultrasounds, 836 (3.3%) fewer colposcopies, and 11 600 (13.8%) fewer colonoscopies than expected in the absence of COVID-19. As of December 2022, in Winnipeg, there were an estimated 6030 (23.9%) fewer elective colonoscopies, 313 (2.6%) fewer semiurgent colonoscopies, and 438 (27.3%) more urgent colonoscopies.
Conclusions
In Manitoba, the COVID-19 pandemic was associated with sizable decreases in diagnostic tests for breast, colorectal, and cervical cancer. Two and a half years later, there remained large cumulative deficits in bilateral mammograms, breast ultrasounds, and colonoscopies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Paul Albrechtsen Research Institute CancerCare Manitoba, Winnipeg, MB, Canada.
- Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
- Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, MB, Canada.
- Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
- Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada.
- Department of Surgery, Section of General Surgery, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
ORCID-Profile: Kathleen M Decker
Förderung
- CancerCare Manitoba Foundation
- Research Manitoba
- Canadian Institutes of Health Research
Zitieren
APA
Decker, K. M., Musto, G., Bucher, O., Czaykowski, P., Hebbard, P., Kim, J. O., Singh, H., Thiessen, M., Feely, A., Galloway, K., & Lambert, P. (2024). Examining the Association Between the COVID-19 Pandemic and the Rate of Diagnostic Tests for Breast, Cervical, and Colorectal Cancer in Manitoba, Canada. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338241263616
Vancouver
Decker KM, Musto G, Bucher O, Czaykowski P, Hebbard P, Kim JO, et al. Examining the Association Between the COVID-19 Pandemic and the Rate of Diagnostic Tests for Breast, Cervical, and Colorectal Cancer in Manitoba, Canada. Technology in Cancer Research & Treatment. 2024. doi:10.1177/15330338241263616
BibTeX
@article{Decker2024,
author = {Decker, Kathleen M and Musto, Grace and Bucher, Oliver and Czaykowski, Piotr and Hebbard, Pamela and Kim, Julian O and Singh, Harminder and Thiessen, Maclean and Feely, Allison and Galloway, Katie and Lambert, Pascal},
title = {Examining the Association Between the COVID-19 Pandemic and the Rate of Diagnostic Tests for Breast, Cervical, and Colorectal Cancer in Manitoba, Canada},
journal = {Technology in Cancer Research & Treatment},
year = {2024},
doi = {10.1177/15330338241263616}
}
EUVIMED